SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-544960
Filing Date
2016-04-18
Accepted
2016-04-18 16:34:33
Documents
3
Period of Report
2016-04-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d184186d8k.htm 8-K 19328
2 EX-99.1 d184186dex991.htm EX-99.1 6408
3 GRAPHIC g184186page5.jpg GRAPHIC 5121
  Complete submission text file 0001193125-16-544960.txt   34134
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36281 | Film No.: 161577219
SIC: 2834 Pharmaceutical Preparations